Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Coo
-
Stock Symbol
-
INZY on Nasdaq
There are no Buy or Sell transactions made by Matthew Winton since 11/5/2023
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
4.9K |
$21.8K |
$4.45 |
Sep 30, 2024 |
Direct |
|
|
| Stock Option (right to buy) |
175K |
|
|
Mar 13, 2024 |
Direct |
Common Stock |
|
Transactions reported by Matthew Winton for Inozyme Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.